DNA Has Relatively Little Say in Disease Risk (Usually)
A meta-analysis of GWAS data suggests that most diseases, including many cancers, diabetes, and Alzheimer’s, have a genetic contribution of 5 to 10 percent at most.
A meta-analysis of GWAS data suggests that most diseases, including many cancers, diabetes, and Alzheimer’s, have a genetic contribution of 5 to 10 percent at most.
Advancements in drug design have resulted in resurging interest in drugs that form covalent bonds with their targets, often referred to as targeted covalent inhibitors.…
So-called “genetic islands” were found not just off the U.K.’s coast. The study also uncovered several on the mainland.
Researchers say the new technology offers scientists optical trapping and tweezing functionality without the overhead of a complicated bulk-optical setup.
Newly launched Judo Bio aims to develop ligand-siRNA conjugates through its Selectively Targeting RNA Into KidnEy (STRIKE) platform.
The 2024 Nobel Prize in Physiology or Medicine was awarded jointly to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role…
The strategic collaboration will provide Recipharm with access to Exela’s manufacturing facility located in Lenoir, NC.
Industry, academic institutions, suppliers, and regulatory agencies working together can yield state-of-the-art downstream processes.
KBI Biopharma says they’re selecting the best technologies to fill gaps in their processes with grassroots help from their scientific staff.
Using miniature human intestines grown in the lab, tuft cells have been found to act as regenerative stem cells in the human intestine.
Researchers recommend verifying success of column-based purification to confirm the presence and availability of the tag on target protein.